LONDON—Covington has joined the newly launched European Life Sciences Coalition (ELSC).
Europe’s life sciences ecosystem stands at a critical turning point. As a founding member of the ELSC, in collaboration with Invest Europe, Covington is pleased to be working closely with investors, biotech innovators, and stakeholders across the life sciences industry to mobilize greater private and public investment into Europe’s life sciences venture capital landscape.
With our international transactional strength, deep regulatory insight, and unparalleled public policy experience, Covington remains uniquely positioned to advise across the full life sciences lifecycle — from early‑stage biotech and academic spinouts to global corporations, investors, and research institutions.
Learn more in the coalition’s announcement here.